News

Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t ...
J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of ...
Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with ...